EquityHealth (NASDAQ:HQY – Get a rating) released an update to its FY23 earnings guidance on Monday morning. The company provided EPS guidance of $1.23 to $1.32 for the period, relative to the consensus EPS estimate. of $1.27. The company released a revenue forecast of $827-837 million, compared to the consensus revenue estimate of $826.17 million.
Shares of HQY traded at $1.61 during midday trading on Monday, rising to $62.45. 878,733 shares of the company were traded, with an average volume of 721,059. The stock has a 50-day moving average price of $63.70 and a 200-day moving average price of $55.95. The company has a market capitalization of $5.27 billion, a price/earnings ratio of -117.83, a P/E/G ratio of 5.55 and a beta of 1.08. HealthEquity has a 1-year low of $36.81 and a 1-year high of $84.71. The company has a current ratio of 2.29, a quick ratio of 2.29 and a debt ratio of 0.50.
EquityHealth (NASDAQ:HQY – Get a rating) last released its quarterly results on Tuesday, March 22. The company reported EPS of $0.09 for the quarter, reaching the consensus estimate of $0.09. HealthEquity posted a positive return on equity of 3.49% and a negative net margin of 5.85%. The company posted revenue of $203.30 million for the quarter, versus $199.27 million expected by analysts. In the same quarter a year earlier, the company posted earnings per share of $0.30. Equity research analysts expect HealthEquity to post 0.6 earnings per share for the current year.
Several research companies have recently commented on HQY. Deutsche Bank Aktiengesellschaft raised its price target on HealthEquity from $62.00 to $66.00 and gave the stock a buy rating in a Thursday, March 24 research note. Wells Fargo & Company began covering HealthEquity in a research note on Monday, April 11. They issued an overweight rating and a price target of $95.00 on the stock. Bank of America raised its price target on HealthEquity from $63.00 to $70.00 in a Wednesday, March 23 research note. Zacks Investment Research upgraded HealthEquity from a strong sell rating to a buy rating and set a price target of $58.00 on the stock in a Tuesday, Feb. 8 research note. To finish, StockNews.com downgraded HealthEquity from a hold rating to a sell rating in a Sunday, March 27 research note. One analyst has rated the stock with a sell rating and thirteen have issued a buy rating for the stock. According to MarketBeat, the stock currently has a consensus buy rating and a consensus price target of $76.71.
Several large investors have recently bought and sold shares of HQY. Morgan Stanley increased its holdings of HealthEquity shares by 133.3% during the second quarter. Morgan Stanley now owns 676,662 shares of the company valued at $54,458,000 after buying an additional 386,663 shares in the last quarter. BNP Paribas Arbitrage SA increased its stake in HealthEquity by 7.9% in the third quarter. BNP Paribas Arbitrage SA now owns 11,856 shares in the company worth $768,000 after purchasing an additional 868 shares last quarter. Goldman Sachs Group Inc. increased its holdings in HealthEquity by 25.6% in the fourth quarter. Goldman Sachs Group Inc. now owns 346,825 shares of the company worth $15,344,000 after buying an additional 70,599 shares last quarter. LPL Financial LLC increased its holdings in HealthEquity by 0.6% in the fourth quarter. LPL Financial LLC now owns 34,062 shares of the company worth $1,504,000 after purchasing an additional 188 shares in the last quarter. Finally, Legal & General Group Plc increased its stake in HealthEquity by 3.9% in the 4th quarter. Legal & General Group Plc now owns 125,759 shares in the company worth $5,564,000 after buying an additional 4,752 shares last quarter. 97.44% of the shares are held by institutional investors.
HealthEquity Company Profile (Get a rating)
HealthEquity, Inc provides technology service platforms to consumers and employers in the United States. The Company offers cloud-based platforms for individuals to make healthcare savings and spending decisions, pay healthcare bills, compare treatment options and prices, receive benefits personalized and clinical information, earn wellness incentives, increase savings, and make investment choices; and health savings accounts.
Get news and reviews for HealthEquity Daily – Enter your email address below to receive a concise daily summary of the latest news and analyst ratings for HealthEquity and related companies with MarketBeat.com’s FREE daily email newsletter.